Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. , today announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd, ...

David Veitch, Chief Executive Officer of Basilea, stated: "We are very pleased with our collaboration with Innoviva Specialty ...